Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.
Saved in:
| Title: | Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma. |
|---|---|
| Authors: | Wakabayashi H; Department of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan. wakabayashi@staff.kanazawa-u.ac.jp., Inaki A; Department of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan., Yoshimura K; Department of Biostatistics, Innovative Clinical Research Center, Kanazawa University Hospital, Ishikawa, Japan., Murayama T; Department of Clinical Development, Kanazawa University Hospital, Ishikawa, Japan., Imai Y; Department of Data Center, Innovative Clinical Research Center, Kanazawa University Hospital, Ishikawa, Japan., Higuchi T; Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Gunma, Japan., Jinguji M; Department of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan., Shiga T; Department of Nuclear Medicine, Hokkaido University, Hokkaido, Japan., Kinuya S; Department of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan. |
| Source: | Scientific reports [Sci Rep] 2022 Jan 19; Vol. 12 (1), pp. 1347. Date of Electronic Publication: 2022 Jan 19. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-022-05239-2 |
